IBEX Preclinical Research

What IBEX Preclinical Research does

IBEX Preclinical Research, Inc. is a privately held contract research organization (CRO) founded in 2003 and headquartered in Logan, Utah. The company provides GLP-compliant and non-GLP preclinical research services to medical device and pharmaceutical sponsors, with a focus on orthopedic, spine, soft tissue, interventional/minimally invasive, and neurosurgical studies. Its 20,000+ square foot AAALAC-accredited facility integrates a 500-square-foot surgical suite, a 10-room animal vivarium, and on-site imaging (CT, OEC Elite fluoroscopy, digital radiography, ultrasound, off-site MRI), enabling end-to-end study execution under one roof. All surgical procedures are performed by veterinarians specifically trained in preclinical research.

The business operates a project-based professional services model, generating revenue through custom protocol design, surgical execution, imaging, and regulatory documentation for FDA submissions. Lead times are quoted as short as 8 weeks from protocol completion, with IACUC review typically under two weeks. Customers are predominantly enterprise MedTech innovators — orthopedic device manufacturers, spine companies, and FDA-focused startups — with additional exposure to physician training programs and pharmaceutical feasibility work. The customer base is anchored by multi-year relationships with unnamed orthopedic device companies (one citing 6 years and multiple models, another 5+ studies), and the firm supplements its direct sales motion with exhibits at NASS, ORS, and the Utah Life Sciences Summit.

The company is owned by Dr. Joshua Packer, a veterinarian who purchased the business in April 2022 after tenure as lead preclinical surgeon at Medtronic Physiological Research Laboratories. Recent strategic activity includes a completed second facility expansion, a 2026 strategic collaboration with Sus Clinicals, and a pending patent (Application 16/916,752) for an ultrasound-guided catheter delivery system, indicating early movement from pure services toward proprietary device IP. IBEX is privately held with no disclosed institutional investors, funding rounds, or revenue figures.

Name

IBEX Preclinical Research

Legal name

IBEX Preclinical Research, Inc.

Website

https://ibexresearch.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

IBEX Preclinical Research is a Utah-based GLP-compliant contract research organization providing orthopedic, spine, soft tissue, and interventional preclinical surgical studies to MedTech and pharmaceutical sponsors in its AAALAC-accredited facility.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) — Preclinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industry

Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)

Keywords

• Preclinical research services
• Medical device testing
• GLP-compliant studies
• Contract research organization
• Surgical model development

Headquarters

HQ city

Logan

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Contract Research Services: Preclinical contract research services for pharmaceutical and medical device companies. Services include GLP and non-GLP studies, animal model testing, surgical procedures, and regulatory support. Revenue generated through project-based contracts for study design, execution, and reporting.
2. Medical Device Testing: Comprehensive medical device testing services including biocompatibility testing, mechanical performance evaluation, and long-term implant safety assessments. Services support FDA submissions and regulatory compliance.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

IBEX Preclinical Research is a contract research organization that designs and executes GLP-compliant and non-GLP preclinical surgical and interventional studies for medical device and pharmaceutical developers. Core work includes in-vivo medical device implantation, safety and efficacy evaluations, custom surgical model development, imaging-based assessments, regulatory documentation, and physician bioskills training delivered through an AAALAC-accredited, 20,000+ sq ft facility.

Product overview

IBEX Preclinical Research is a contract research organization (CRO) offering a unified preclinical research platform centered on GLP-compliant medical device testing services. The company provides eight integrated service modules: Medical Device Testing (including biocompatibility and mechanical performance), Orthopedics and Bone Regeneration, Soft Tissue Surgery, Bioskills and Cadaver Studies, Custom Procedures, Interventional and Minimally Invasive testing, and Physician Training. All services are conducted in-house within their AAALAC-accredited 20,000+ square foot facility, combining surgical capabilities with advanced imaging technologies (fluoroscopy, CT, digital radiography, ultrasound) to support device validation from feasibility through regulatory submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Device Testing

Quantifiable outcome

• Lead times as short as 8 weeks from protocol completion to study start
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Sus ClinicalscoreStrategic or Co-development Partner · 1 April 2026Strategic collaboration announced in April 2026 for expanded preclinical research capabilities and services
• Utah State University-Office of Veterinary ResearchcoreStrategic or Co-development PartnerPartnership with Utah State University for veterinary research collaboration, providing academic-industry linkage and research expertise access
• Bridgerland Technical CollegecoreStrategic or Co-development PartnerPartnership with Bridgerland Technical College supporting workforce development and training in preclinical research field
• BIO UtahminorChannel Partner/ Reseller/ DistributorPartnership and membership with BIO Utah, the state's biotechnology industry organization, providing networking and industry advocacy

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Inotiv: Preclinical CRO providing surgical, toxicology, and medical device study services with GLP-compliant infrastructure; comparable in offering mix to IBEX, though operating at materially larger scale across multiple US sites.
• CBSET (Altasciences Preclinical): Now part of Altasciences, CBSET is a preclinical CRO with deep focus on medical devices, interventional therapies and GLP-compliant studies — directly comparable to IBEX's medical device, interventional, and orthopedic preclinical franchise.
• PreClinResearch (PCR) / NAMSA: NAMSA is a medical-device-focused CRO providing preclinical, biocompatibility, and regulatory services — a very close comparator to IBEX's device-centric, GLP preclinical business model.
• American Preclinical Services (APS): Preclinical CRO specializing in surgical, interventional, and medical device studies using large animal models; very close analog to IBEX's interventional, orthopedic, and soft tissue franchise.
• Toxikon (formerly Toxikon): Preclinical CRO with strong medical device and biocompatibility testing focus (ISO 10993), directly overlapping IBEX's device testing and biocompatibility offering.
• Frontage Laboratories: Preclinical CRO offering safety, medical device, and bioanalytical services; comparable on the medical device preclinical side, with broader capabilities in regulated bioanalytics.

Broad incumbents

• WuXi AppTec: Global CRO/CDMO with a substantial preclinical safety and medical device testing business; competes for outsourced preclinical work and operates as a broad incumbent relative to IBEX.
• Charles River Laboratories: Global preclinical CRO offering a much broader portfolio including safety assessment, DMPK, and biologics; competes for the same medical device and surgical preclinical RFPs as IBEX but at significantly larger scale and footprint.
• Labcorp (Labcorp Drug Development / Early Development): Operates one of the largest preclinical and central laboratory networks globally, including medical device and surgical safety studies; broad incumbent competitor with overlapping GLP preclinical services.
• Eurofins Scientific: Global testing services platform with preclinical, medical device, and biocompatibility capabilities; broader portfolio but with overlapping device-testing services where IBEX competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IBEX Preclinical Research